Current Value of Holding

$523 Million

Shares

5.33 Million

% of Portfolio

0.81%

Average Buy Price

$74

Avg closing price
Price range

46 Jim Simons Gilead Sciences Trades

Jim Simons's position in Gilead Sciences is currently worth $523 Million. That's 0.81% of their equity portfolio (12th largest holding). The first Gilead Sciences trade was made in Q2 2013. Since then Jim Simons bought shares 22 more times and sold shares on 23 occasions. The stake costed the investor $394 Million, netting the investor a gain of 33% so far.

Avg closing price
Price range
Increased shares by 27.2% (+1.14 Million shares) Q4 2024
Avg closing price $90.22
Price range $83.94 - $97.90
Sold 17.2% shares (-869 Thousand shares) Q3 2024
Avg closing price $76.20
Price range $66.59 - $83.99
Increased shares by 17.1% (+740 Thousand shares) Q2 2024
Avg closing price $66.73
Price range $63.15 - $72.88
Sold 22.6% shares (-1.26 Million shares) Q1 2024
Avg closing price $76.90
Price range $71.58 - $87.29
Sold 13.5% shares (-868 Thousand shares) Q4 2023
Avg closing price $77.82
Price range $73.27 - $83.09
Sold 17.2% shares (-1.34 Million shares) Q3 2023
Avg closing price $76.92
Price range $73.94 - $80.67
Sold 26.5% shares (-2.8 Million shares) Q2 2023
Avg closing price $79.75
Price range $76.01 - $86.70
Increased shares by 15.0% (+1.38 Million shares) Q1 2023
Avg closing price $82.82
Price range $77.31 - $88.08
Sold 8.2% shares (-820 Thousand shares) Q4 2022
Avg closing price $79.19
Price range $62.32 - $89.47
Sold 25.3% shares (-3.39 Million shares) Q3 2022
Avg closing price $63.06
Price range $59.54 - $68.01
Sold 13.4% shares (-2.08 Million shares) Q2 2022
Avg closing price $61.91
Price range $57.72 - $65.01
Increased shares by 70.6% (+6.41 Million shares) Q1 2022
Avg closing price $63.92
Price range $57.92 - $72.58
Increased shares by 65.1% (+3.58 Million shares) Q4 2021
Avg closing price $68.88
Price range $64.88 - $73.64
Increased shares by 9.0% (+454 Thousand shares) Q3 2021
Avg closing price $70.25
Price range $67.69 - $73.03
Sold 23.1% shares (-1.51 Million shares) Q2 2021
Avg closing price $66.77
Price range $63.47 - $69.35
Increased shares by 2.9% (+186 Thousand shares) Q1 2021
Avg closing price $64.48
Price range $60.00 - $68.46
Sold 16.7% shares (-1.28 Million shares) Q4 2020
Avg closing price $60.34
Price range $56.65 - $64.55
Sold 14.0% shares (-1.25 Million shares) Q3 2020
Avg closing price $69.35
Price range $62.10 - $78.08
Sold 29.0% shares (-3.63 Million shares) Q2 2020
Avg closing price $76.64
Price range $72.34 - $84.00
Sold 26.1% shares (-4.43 Million shares) Q1 2020
Avg closing price $69.10
Price range $62.63 - $80.22

News about Gilead Sciences, Inc. and Jim Simons

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!